YM-17E

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameYM-17E

Drug Alias NameYM-17E

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors

TargetsAcyl coenzyme A:cholesterol acyltransferase

Therapy Area/IndicationsHyperlipidemias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHyperlipidemias

ATC CodeN/A